DBVT Q3 2020 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+50.9% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$30M-715.8% margin

Net Income

-$31M-744.5% margin

EPS (Diluted)

$-2.80

QoQ Revenue Growth

+15.2%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

-$74,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+50.9%
Gross Profit	$4M	$3M	+50.9%
Operating Income	-$30M	-$31M	+4.2%
Net Income	-$31M	-$31M	+0.1%